Flatiron Health enhances cancer care and research through its cancer-specific Electronic Health Record (EHR) system, which helps healthcare providers manage patient information and integrates real-world data for better outcomes. The platform connects various stakeholders in oncology, facilitating collaboration and data sharing to accelerate research and improve care quality. Unlike competitors, Flatiron not only offers its EHR on a subscription basis but also collaborates with life sciences companies to provide access to extensive real-world data for developing new treatments. The company's goal is to transform oncology by leveraging data quality and improving patient care.

First Round Capital

LabCorp

Social Capital

Roche Venture Fund

BoxGroup

Allen & Company

Roche

Edward Zimmerman

SV Angel

IA Ventures

Aaron Levie

David Tisch

Stripes

Andreessen Horowitz

Jared Hecht

Jack Abraham

Great Oaks Venture Capital

Grape Arbor VC

GC Capital

Biotechnology

Healthcare

Flatiron Health

Willowglade, Flatiron Health Partner to Enhance the Oncology Patient Experience. by Syed Hamza Sohail 11/22/2024 Leave a Comment. What You Should Know:– Willowglade Technologies®, provider of the only Unified Digital Patient Experience™ Platform available to oncology practices nationwide, announced a new partnership with Flatiron Health, a leading healthtech company dedicated to expanding the possibilities of point of care solutions in oncology.– The partnership aims to enhance patient centered care by expanding the availability of the Unified Digital Patient Experience™ Platform to practices using Flatiron’s OncoEMR®, a leading cloud based electronic medical record.Transforming Oncology Care: Willowglade and Flatiron’s Unified Digital Patient ExperienceTM Platform The Unified Digital Patient ExperienceTM Platform by Willowglade represents a transformative advancement in patient-centered care. By consolidating multiple functionalities into a single platform, the solution enhances communication and collaboration between patients and providers, offering: – Access to appointment itineraries, telehealth visits, and secure messaging. – Completion of Smart eForms, Patient Reported Outcomes (ePROs), and surveys. – Viewing of lab results, clinical documents, and physician-validated triage symptom pathways. – Participation in Care Management programs, such as Principal Care Management (PCM). In partnership with Flatiron, Willowglade aims to simplify operational processes and technical integrations for oncology practices. By replacing up to five stand-alone systems, the combined platforms streamline business and clinical operations while enhancing the patient experience. This collaboration underscores a commitment to revolutionizing oncology care by integrating advanced digital tools to deliver seamless, effective, and patient-centric solutions

Willowglade, Flatiron Health Partner To Enhance The Oncology Patient Experience

- Willowglade Technologies(R), provider of the only Unified Digital Patient Experience(TM) Platform available to oncology practices nationwide, announced a new partnership with Flatiron Health, a leading healthtech company dedicated to expanding the possibilities of point of care solutions in oncology.

Willowglade, Flatiron Health Partner to Enhance the Oncology Patient Experience

Tempus announced a collaboration with Flatiron Health to integrate its genomic testing capabilities into Flatiron's OncoEMR(R) platform through Molecular Profiling Integration (MPI).

Tempus Molecular Profiling Integration Now Available Through Flatiron's OncoEMR(R)

NEW YORK - Myriad Genetics said Tuesday that it has entered a new collaboration with Flatiron Health, a Roche company, that will make its MyRisk hereditary cancer test available for physicians to order through Flatiron's cloud-based electronic medical record system OncoEMR.

Myriad Genetics, Flatiron Health Partner on EMR Integration of MyRisk Hereditary Cancer Test

University Hospitals of Leicester NHS Trust, one of the largest acute hospital trusts in the UK, has partnered with Flatiron Health UK to translate Leicester, Leicestershire and Rutland's cancer patient records into high-quality data to expand cancer research opportunities.

Transforming Cancer Care: Flatiron Health UK Partners with University Hospitals of Leicester NHS Trust to Advance Cancer Research

Seasoned leader will oversee expanding solutions to support clinicians in providing the best possible patient care
Flatiron Health, a leading healthtech company dedicated to expanding the possibilities of point of care solutions in oncology, today announced Quincy Weatherspoon as Vice President and General Manager of Flatiron Point of Care Solutions, effective September 1, 2024.

Flatiron Health announces Quincy Weatherspoon as Vice President and General Manager for point of care business

NEW YORK--(BUSINESS WIRE)--Flatiron Health today announced its significant presence at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting, to be held in Chicago this June. Nine abstracts led by Flatiron have been accepted for poster presentation and online publication. A comprehensive of all accepted research using Flatiron data is available via ASCO's website. Aligned with the conference theme, 'The Art and Science of Cancer Care: From Comfort to Cure,' Flatiron is dedicated to spearheading evidence generation in oncology. This year’s accepted research reflects that dive into critical touch points across the oncology ecosystem. “At Flatiron, we're pioneering new approaches to address health equity, enhance clinical trials, and bridge the gap between routine care and research,” stated Neal Meropol, VP of Research Oncology, Flatiron Health

Flatiron Health Announces Research To Be Presented At American Society Of Clinical Oncology 2024 Annual Meeting

NEW YORK--(BUSINESS WIRE)--Flatiron Health, a leading healthtech company dedicated to expanding the possibilities of point of care solutions in oncology and closing the gap between care and research, today announced a collaboration with the Association of Cancer Care Centers (ACCC), a powerful network of more than 40,000 multidisciplinary practitioners from cancer care communities nationwide, to promote increased access to cancer clinical trials in the community setting and provide member practices with access to Flatiron Clinical Pipe™, a cutting-edge electronic health record (EHR) to electronic data capture (EDC) connector that improves efficiency and reduces time and effort of clinical study data capture. "This collaboration with Flatiron Health marks a significant moment for us at ACCC. By bringing cutting-edge tech to our community cancer centers, this partnership will make clinical trials more accessible, streamline data management, and help us deliver improved care to our patients across cancer care settings more efficiently and effectively,” said Sumanta K. Pal, MD, FASCO, Chair, ACCC’s Community Oncology Research Institute (ACORI). “We look forward to continuing our work together to realize the full impact and value our partnership can bring to improve the experience of every person with cancer.”. With over 50 years’ experience, ACCC is a leader in the cancer care community that brings together stakeholders to create comprehensive solutions that positively impact the patient experience and patient outcomes

The Association Of Cancer Care Centers And Flatiron Health Announce A Strategic Collaboration To Improve Study Data Capture

What You Should Know:– Flatiron Health, an oncology-focused healthtech company, and the Association of Cancer Care Centers (ACCC), a powerful network of cancer care professionals, are proud to announce a new collaboration.– The partnership aims to make cancer clinical trials more accessible to patients in community settings and empower healthcare providers with cutting-edge data capture technology.Boosting Clinical Trial ParticipationACCC boasts over 40,000 members across diverse cancer care specialties. Through this collaboration, Flatiron and ACCC will work together to:Increase access to clinical trials: The partnership will focus on promoting participation in cancer clinical trials within community-based practices. This will give patients greater access to potentially life-saving treatment options closer to home.Revolutionizing Data CaptureFlatiron’s innovative technology, Flatiron Clinical Pipe™, plays a central role in this initiative.What is Flatiron Clinical Pipe? This state-of-the-art tool seamlessly connects electronic health records (EHR) to electronic data capture (EDC) systems. This translates to: Faster data capture: Flatiron Clinical Pipe streamlines the process of capturing both structured and unstructured clinical trial data, saving valuable time and resources. Improved accuracy: Efficient data transfer minimizes errors and ensures data integrity.Benefits for EveryoneBy leveraging Flatiron Clinical Pipe, ACCC member practices will experience significant benefits, including:Reduced workload: Faster data capture frees up valuable staff time to focus on patient care.Faster data capture frees up valuable staff time to focus on patient care. Increased research participation: Streamlined data collection allows practices to participate in more clinical trials, offering patients access to the latest treatment options.Streamlined data collection allows practices to participate in more clinical trials, offering patients access to the latest treatment options

Flatiron & Accc Partner To Expand Community Oncology Clinical Trials

What You Should Know:– Flatiron Health, a provider of real-world data (RWD) for cancer care, and the National Comprehensive Cancer Network® (NCCN®), an alliance of top cancer centers, have announced a renewal of their long-standing collaboration.– This decade-long partnership, dating back to 2014, focuses on leveraging RWD to improve cancer care and research.The Power of Real-World Data in Cancer CareReal-world data offers a valuable window into the realities of cancer care beyond clinical trials. By analyzing data from real-world settings, researchers and healthcare providers can gain a deeper understanding of treatment effectiveness, identify potential disparities in care, and ultimately improve patient outcomes.Collaboration for Better Cancer Care with RWDThe renewed collaboration signifies a continued commitment to leveraging RWD for positive impact. This will involve several key initiatives:Expanding Real-World Data Research: Flatiron and NCCN will work together to enable further research using RWD. This research will provide valuable insights into real-world treatment patterns and patient outcomes.Flatiron and NCCN will work together to enable further research using RWD. This research will provide valuable insights into real-world treatment patterns and patient outcomes. Improving Cancer Care Nationwide: Cancer centers across the country will benefit from access to Flatiron’s high-quality, curated datasets

Flatiron Health, Nccn Collaborate To Advance Cancer Care With Real-World Data

Cancer-specific electronic health record platform

Flatiron Health

Cancer-specific electronic health record platform

Flatiron Health

Cancer-specific electronic health record platform

About

Simplify's Take

What believers are saying

What critics are saying

What makes Flatiron Health unique

6 month growth

1 year growth

2 year growth

Benefits

Recently Posted Jobs

Flatiron Health is Hiring for 0 Jobs on Simplify!